Quantitative estimation of the degree of hepatic macrovesicular steatosis in a disease‐free population: A single‐center experience in mainland China

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Liver transplantation

• Publication date

  2009-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/lt.21812PMID 19877230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Imaging evaluation of potential donors in living-donor liver transplantation.

  2008cited by this paper
• Non-alcoholic fatty liver disease: the mist gradually clears.

  2008influential reference
• Effect of graft steatosis on liver function and organ survival after liver transplantation.

  2008cited by this paper
• Relationship Among Histologic, Radiologic, and Biochemical Assessments of Hepatic Steatosis: A Study of Human Liver Samples

  2007cited by this paper
• Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index.

  2007cited by this paper
• Non‐alcoholic fatty liver disease in the Asia–Pacific region: Definitions and overview of proposed guidelines

  2007cited by this paper
• Imaging of hepatic steatosis and fatty sparing.

  2007cited by this paper
• Measures for increasing the safety of donors in living donor liver transplantation using right lobe grafts.

  2007cited by this paper
• How should we manage patients with non‐alcoholic fatty liver disease in 2007?

  2007cited by this paper
• Cause-specific excess deaths associated with underweight, overweight, and obesity.

  2007cited by this paper
• Donor liver dysfunction: application of a new scoring system to identify the marginal donor.

  2007cited by this paper
• Complications in the right lobe adult living donor: single-center experience in China.

  2007cited by this paper
• Preliminary experience for reducing biliary complication in adult‐to‐adult living donor liver transplantation using right lobe graft

  2007cited by this paper
• Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment.

  2006influential reference
• Safety of donors with fatty liver in liver transplantation.

  2006cited by this paper
• Saying “yes” to obese living liver donors: Short‐term intensive treatment for donors with hepatic steatosis in living‐donor liver transplantation. Nakamuta M, Morizono S, Soejiima Y, Yoshizumi T, Aishima S, Takasugi S, et al. Transplantation 2005;80:608–612.

  2006cited by this paper
• Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbilirubinemia during regeneration after living donor liver transplantation

  2006cited by this paper
• Living donor liver transplantation: Histological abnormalities found on liver biopsies of apparently healthy potential donors

  2006cited by this paper
• A review of international and UK-based ethical guidelines for researchers conducting nontherapeutic genetic studies in developing countries

  2006cited by this paper
• Risks and benefits.

  2006cited by this paper
• Micro- and macrovesicular steatotic liver model for transplantation induced by ethanol and protein-deficient diet.

  2005cited by this paper
• Donor liver steatosis and graft selection for liver transplantation: a short review.

  2005cited by this paper
• Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial

  2005cited by this paper
• Short-Term Intensive Treatment for Donors with Hepatic Steatosis in Living-Donor Liver Transplantation

  2005cited by this paper
• Hepatic MRI for Fat Quantitation: Its Relationship to Fat Morphology, Diagnosis, and Ultrasound

  2005cited by this paper
• Preoperative donor liver biopsy for adult living donor liver transplantation: Risks and benefits

  2005cited by this paper
• Obesity in potential living donors: Success with simplicity

  2004cited by this paper
• Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings.

  2004influential reference
• MICRO- AND MACROVESICULAR STEATOTIC LIVER MODEL FOR TRANSPLANTATION INDUCED BY ETHANOL AND PROTEIN DEFICIENT DIET

  2004cited by this paper
• Noninvasive Evaluation of Graft Steatosis in Living Donor Liver Transplantation

  2004cited by this paper
• The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation

  2004cited by this paper
• Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation

  2003cited by this paper
• Evaluation of the donor liver for living donor liver transplantation

  2003cited by this paper
• The intraclass correlation coefficient applied for evaluation of data correction, labeling methods, and rectal biopsy sampling in DNA microarray experiments.

  2003cited by this paper
• Liver biopsy in living donors

  2002cited by this paper
• Body mass index as a predictor of hepatic steatosis in living liver donors

  2001influential reference
• ASSESSMENT OF DONOR FATTY LIVERS FOR LIVER TRANSPLANTATION1

  2001cited by this paper
• Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy

  2000cited by this paper
• Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test

  2000cited by this paper
• Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?

  1989cited by this paper

• Trends of liver transplantation in Asia

  2024cites this paper
• Development of a model to predict the risk of early graft failure after adult-to-adult living donor liver transplantation: An ELTR study

  2023cites this paper
• Liver transplantation in China: Achievements over the past 30 years and prospects for the future.

  2022cites this paper
• Comparison of computed tomography hepatic steatosis criteria for identification of abnormal liver function and clinical risk factors, in incidentally noted fatty liver

  2020cites this paper
• Marit Kalisvaart [8347] Binnenwerk v6.split.indd

  2018cites this paper
• The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation.

  2017cites this paper
• Comparison of correlations between lipid profile and different computed tomography fatty liver criteria in the setting of incidentally noted fatty liver on computed tomography examinations

  2017cites this paper
• How to Perform Selective Liver Biopsy in Living Liver Donors Using Plain Computed Tomography.

  2016cites this paper
• Donor Safety in Adult-Adult Living Donor Liver Transplantation: A Single-Center Experience of 356 Cases

  2016influential citation
• How to Perform Selective Liver Biopsy in Living Liver Donors Using Plain Computed Tomography

  2016cites this paper
• Chapter 84 – Histopathology of Liver Transplantation

  2015cites this paper
• Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver‐to‐spleen attenuation ratio

  2015cites this paper
• Quantitative Assessment of Liver Fat in an Obese Patient Population Using Non-contrast CT Fat Percent Index

  2014influential citation
• Assessment of liver fat in an obese patient population using noncontrast CT fat percent index.

  2014influential citation
• Assessment of hepatic steatosis by transplant surgeon and expert pathologist: A prospective, double‐blind evaluation of 201 donor livers

  2013cites this paper
• Nonalcoholic Fatty Liver Disease and HIV Infection

  2012cites this paper
• Pretransplant Prediction of Posttransplant Survival for Liver Recipients with Benign End-Stage Liver Diseases: A Nonlinear Model

  2012cites this paper
• Posttransplant mortality risk assessment for adult-to-adult right-lobe living donor liver recipients with benign end-stage liver disease

  2012cites this paper
• Mortality risk after liver transplantation in hepatocellular carcinoma recipients: a nonlinear predictive model.

  2012cites this paper
• Are There Better Guidelines for Allocation in Liver Transplantation?: A Novel Score Targeting Justice and Utility in the Model for End-Stage Liver Disease Era

  2011cites this paper
• Four‐year follow‐up of two chronic hepatitis B recipients of hepatitis B surface antigen‐positive cadaveric liver grafts from asymptomatic carriers

  2011cites this paper
• Evaluation outcomes of donors in living donor liver transplantation: a single-center analysis of 132 donors.

  2011cites this paper
• Non-contrasted Computed Tomography for the Accurate Measurement of Liver Steatosis in Obese Patients

  2011cites this paper
• C-terminal peptide of anaphylatoxin C3a enhances hepatic function after steatotic liver transplantation: a study in a rat model.

  2010cites this paper
• Noninvasive imaging biomarkers for steatosis assessment

  2009cites this paper